Article

 

Identification of the primary peptide contaminant that inhibits fibrillation and toxicity in synthetic amyloid-β42. Public Deposited

Downloadable Content

Download PDF
https://scholar.colorado.edu/concern/articles/jw827c31x
Abstract
  • Understanding the pathophysiology of Alzheimer disease has relied upon the use of amyloid peptides from a variety of sources, but most predominantly synthetic peptides produced using t-butyloxycarbonyl (Boc) or 9-fluorenylmethoxycarbonyl (Fmoc) chemistry. These synthetic methods can lead to minor impurities which can have profound effects on the biological activity of amyloid peptides. Here we used a combination of cytotoxicity assays, fibrillation assays and high resolution mass spectrometry (MS) to identify impurities in synthetic amyloid preparations that inhibit both cytotoxicity and aggregation. We identify the Aβ42Δ39 species as the major peptide contaminant responsible for limiting both cytotoxicity and fibrillation of the amyloid peptide. In addition, we demonstrate that the presence of this minor impurity inhibits the formation of a stable Aβ42 dimer observable by MS in very pure peptide samples. These results highlight the critical importance of purity and provenance of amyloid peptides in Alzheimer's research in particular, and biological research in general.
Creator
Date Issued
  • 2017-01-01
Academic Affiliation
Journal Title
Journal Issue/Number
  • 8
Journal Volume
  • 12
File Extent
  • 0182804-0182804
Subject
Last Modified
  • 2019-12-05
Identifier
  • PubMed ID: 28792968
Resource Type
Rights Statement
DOI
ISSN
  • 1932-6203
Language
License

Relationships

Items